Home: PCU 1|2004: Faculty Disclosures

FACULTY DISCLOSURES

As a provider accredited by the ACCME, it is the policy of Research To Practice to require the disclosure of any significant financial interest or any other relationship the sponsor or faculty members have with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The presenting faculty reported the following:


Peter R Carroll, MD Grants/Research Support: TAP Pharmaceuticals Inc Consultant: iMetrikus Inc Honorarium: AstraZeneca Pharmaceuticals LP
Matthew R Smith, MD, PhD Grants/Research Support and Consultant: AstraZeneca Pharmaceuticals LP, Novartis Oncology
Arif Hussain, MD Grants/Research Support: AstraZeneca Pharmaceuticals LP, Aventis Pharmaceuticals Inc, Berlex Inc, Bristol-Myers Squibb Company, Cytogen Corporation, Novartis Pharmaceuticals, Pfizer Inc Consultant: Cytogen Corp

This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the FDA. Research To Practice does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. The opinions expressed are those of the presenters and are not to be construed as those of the publisher or grantor.

 

 

 
   

Home

Editor’s Note:
Doctors with cancer

Peter R Carroll, MD
    - Select publications

Matthew R Smith, MD, PhD
    - Select publications

Arif Hussain, MD
    - Select publications

CME Information

Faculty Disclosures

Editor’s Office

 
Terms of use and general disclaimer
© Research To Practice, 2004. All rights reserved.